Contribution of baseline body mass index and leptin serum level to the prediction of early weight gain with atypical antipsychotics in schizophrenia.

Psychiatry and clinical neurosciences

Volumn 68, Issue 2, 2014, Pages 127-132

  Cortés, Benjamín ^a   Bécker, Joemir ^b   Mories Álvarez, María Teresa ^b   Marcos, Ana I Sánchez ^b   Molina, Vicente ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; LEPTIN; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; BLOOD; BODY MASS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SCHIZOPHRENIA; WEIGHT GAIN; YOUNG ADULT;

CLOZAPINE; LEPTIN; OLANZAPINE; RISPERIDONE; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; OVERWEIGHT; SCHIZOPHRENIA; WEIGHT GAIN; YOUNG ADULT;

EID: 84907875280     PISSN: None     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/pcn.12110     Document Type: Article

References (0)